• Home
  • Store
    • Newsletter Subscriptions
    • Multimedia
    • Books
    • eBooks
    • ABPN SA Courses
    • Social Work Courses
  • CME Center
  • Multimedia
    • Podcast
    • Webinars
    • Blog
    • Psychiatry News Videos
    • Medication Guide Videos
  • Newsletters
    • General Psychiatry
    • Child Psychiatry
    • Addiction Treatment
    • Hospital Psychiatry
    • Geriatric Psychiatry
    • Psychotherapy and Social Work
  • FAQs
  • Med Fact Book Apps
  • Log In
  • Register
  • Welcome
  • Sign Out
  • Subscribe
Home » cannabis

Articles Tagged with ''cannabis''

CGPR_shutterstock_1433830391.png
Expert Q&A

Cannabis Use for Managing Agitation in Dementia

January 1, 2024
Aaron Greenstein, MD.
From The Carlat Geriatric Psychiatry Report
Issue Links: Editorial Information | PDF of Issue

QA1_Aaron Greenstein_Headshot.jpgAaron Greenstein, MD.

Geriatric psychiatrist in private practice, Denver, CO. Dr. Greenstein is a medical advisor for BrainCheck, Sensi.AI, and Optimize VBC. He is a consultant for GE Healthcare and LEK Consulting.

Relevant financial relationships listed for the author have been mitigated.

Dr. Aaron Greenstein describes when to use dronabinol and dispensary cannabis products for treating agitation in dementia.


Read More
RESEARCH UPDATE

Can Smoking Marijuana Reduce PTSD Symptoms?

September 1, 2023
Gregory Lande, MD.
From The Carlat Addiction Treatment Report
Issue Links: Editorial Information | PDF of Issue

Gregory Lande, MD. Dr. Lande, author of this educational activity, has no relevant financial relationship(s) with ineligible companies to disclose.

Many states have passed laws allowing the prescription of cannabis as a treatment for PTSD in spite of the absence of high-quality evidence. In this prospective, double-blinded trial, researchers failed to find evidence that either THC or CBD is an effective treatment for PTSD.


Read More
Expert Q&A

Substance Use Disorders in Older Adults: A Growing Concern

May 11, 2023
Olivera J. Bogunovic, MD
From The Carlat Geriatric Psychiatry Report
Issue Links: Editorial Information | PDF of Issue

QA2_OliveraBogunovicHeadshot.jpegOlivera J. Bogunovic, MD.

Medical director of ambulatory services in the Division of Alcohol, Drugs, and Addiction at McLean Hospital, Belmont, MA; assistant professor of psychiatry, Harvard Medical School, Boston, MA.

Dr. Bogunovic has no financial relationships with companies related to this material.

Older adults with substance use disorders present to clinicians in various stages of change. Dr. Bogunovic discusses brief clinical interventions including motivational interviewing and how to approach harm reduction.


Read More
CGPR2023_canstockphoto77741530.jpg
Expert Q&A

Managing Substance Use in Older Adults

May 9, 2023
Louis Trevisan, MD.
From The Carlat Geriatric Psychiatry Report
Issue Links: Editorial Information | PDF of Issue

Louis Trevisan, MD. 

Clinical professor of psychiatry, Creighton University School of Medicine, Omaha, NE; associate professor of psychiatry, adjunct, Yale School of Medicine, New Haven, CT.

Dr. Trevisan has no financial relationships with companies related to this material. 

How do we best approach screening for substance use disorders in older adults? Dr. Trevisan walks us through his approach to choosing the right screening tools and speaking with patients.


Read More
Clinical Update

Screening Tools, Assessment, and Brief Interventions for Substance Use Disorders in Older Adults

May 9, 2023
Julia Cromwell, MD
From The Carlat Geriatric Psychiatry Report
Issue Links: Editorial Information | PDF of Issue

Julia Cromwell, MD. Inpatient geriatric psychiatrist, Mass General Brigham Salem Hospital, Salem, MA.

Dr. Cromwell has no financial relationships with companies related to this material.

How do you choose a screening tool for substance use disorders in older adults, and what do you do when a patient screens positive? We discuss common screening tools, assessments, and interventions based on an older adult’s risk level.


Read More
testresults.jpeg
Expert Q&A

Interpreting Urine Drug Tests

April 1, 2023
Karen Moeller, PharmD
From The Carlat Hospital Psychiatry Report
Issue Links: Editorial Information | PDF of Issue

QA1_UrineDrugScreens_Moeller_headshot.jpgKaren Moeller, PharmD. Clinical professor, Department of Pharmacy Practice, University of Kansas School of Pharmacy. Lawrence, KS. Board-certified psychiatric pharmacist, inpatient psychiatry unit, University of Kansas Health Systems. Kansas City, KS.

Dr. Moeller has no financial relationships with companies related to this material.

Drug screen accuracy depends on several factors, including the type of lab test, the number of hours since the patient’s use of the drug, and more.. Dr. Moeller reviews key points.


Read More
Research Update

Are Higher-Potency Cannabis Products Riskier for Mental Illness?

April 1, 2023
Deepti Anbarasan, MD and John Wang, MD
From The Carlat Addiction Treatment Report
Issue Links: Editorial Information | PDF of Issue

John Wang, MD, and Deepti Anbarasan, MD. Dr. Wang and Dr. Anbarasan have no financial relationships with companies related to this material.

In recent years, cannabis with widely varying THC concentrations has become available. But is there a link between how much THC a cannabis product contains and its risk of adverse effects. Researchers here add to the mounting evidence that the answer is likely yes.


Read More
psychosis.jpeg
Expert Q&A

Recognizing and Treating Substance-Induced Psychosis

April 1, 2023
David Beckmann, MD, MPH
From The Carlat Addiction Treatment Report
Issue Links: Editorial Information | PDF of Issue

CATR_QA1_Beckmann headshot_color.jpgDavid Beckmann, MD, MPH. 

Assistant professor of psychiatry and human behavior, Sidney Kimmel Medical College, Thomas Jefferson University. Philadelphia, PA.

Dr. Beckmann has no financial relationships with companies related to this material.

Clinical pearls on how to assess and treat substance-induced psychosis when you come across them in your clinic.


Read More
Clinical Update

Naltrexone: A Jack of All Trades?

April 1, 2023
Julio Cesar Nunes, MD
From The Carlat Addiction Treatment Report
Issue Links: Editorial Information | PDF of Issue

Julio Cesar Nunes, MD. Psychiatry resident, Yale University. New Haven, CT.

Noah Capurso, MD, MHS. Assistant professor of psychiatry, Yale University. New Haven, CT. Editor-in-chief of The Carlat Addiction Treatment Report.

Dr. Nunes and Dr. Capurso have no financial relationships with companies related to this material.

Naltrexone was once hailed as a treatment for all addictive disorders. While the hype has not entirely panned out, it still holds an important place in our armamentarium of addiction treatments. Here, we review the evidence for its use and provide prescribing recommendations.


Read More
RESEARCH UPDATE

Driving Performance and Cannabis Users’ Perception of Safety: A Randomized Trial

January 30, 2023
Olaniyi Olayinka, MD.
From The Carlat Addiction Treatment Report
Issue Links: Editorial Information | PDF of Issue

Olaniyi Olayinka, MD. Dr. Olayinka has no financial relationships with companies related to this material.

Everyone knows that drinking alcohol can impair driving ability. Researchers here demonstrate that driving under the influence of cannabis can be risky as well.


Read More
Previous 1 2 3 4 Next
Carlat Total Access Subscriptions: Get access to every article on the website.

Complete access to every article you search on the website.

Shop for Total Access
Free Psychiatry Updates
The latest unbiased psychiatric information sent to your inbox.
Specify Your Interests
Featured Book
  • HospPsychiatry_Spiral_Binding_Sm.png

    Hospital Psychiatry Fact Book, First Edition (2025) - Spiral Bound

    This comprehensive guide is designed to be a valuable resource for professionals working in...
    READ MORE
Featured Video
  • KarXT (Cobenfy)_ The Breakthrough Antipsychotic That Could Change Everything.jpg
    General Psychiatry

    KarXT (Cobenfy): The Breakthrough Antipsychotic That Could Change Everything

    Read More
Featured Podcast
  • shutterstock_2637648401.jpg
    General Psychiatry

    Psychopharm Secrets: Coming Off Meds

    There’s a hidden placebo response to watch for when patients stop meds on their own.
    Listen now
Recommended
  • Join Our Writing Team

    July 18, 2024
    WriteForUs.png
  • Insights About a Rare Transmissible Form of Alzheimer's Disease

    February 9, 2024
    shutterstock_2417738561_PeopleImages.com_Yuri A.png
  • How to Fulfill the DEA's One Time, 8-Hour Training Requirement for Registered Practitioners

    May 24, 2024
    DEA_Checkbox.png
  • Join Our Writing Team

    July 18, 2024
    WriteForUs.png
  • Insights About a Rare Transmissible Form of Alzheimer's Disease

    February 9, 2024
    shutterstock_2417738561_PeopleImages.com_Yuri A.png
  • How to Fulfill the DEA's One Time, 8-Hour Training Requirement for Registered Practitioners

    May 24, 2024
    DEA_Checkbox.png
  • Join Our Writing Team

    July 18, 2024
    WriteForUs.png
  • Insights About a Rare Transmissible Form of Alzheimer's Disease

    February 9, 2024
    shutterstock_2417738561_PeopleImages.com_Yuri A.png
  • How to Fulfill the DEA's One Time, 8-Hour Training Requirement for Registered Practitioners

    May 24, 2024
    DEA_Checkbox.png

About

  • About Us
  • CME Center
  • FAQ
  • Contact Us

Shop Online

  • Newsletters
  • Multimedia Subscriptions
  • Books
  • eBooks
  • ABPN Self-Assessment Courses

Newsletters

  • The Carlat Psychiatry Report
  • The Carlat Child Psychiatry Report
  • The Carlat Addiction Treatment Report
  • The Carlat Hospital Psychiatry Report
  • The Carlat Geriatric Psychiatry Report
  • The Carlat Psychotherapy Report

Contact

carlat@thecarlatreport.com

866-348-9279

PO Box 626, Newburyport MA 01950

Follow Us

Please see our Terms and Conditions, Privacy Policy, Subscription Agreement, Use of Cookies, and Hardware/Software Requirements to view our website.

© 2025 Carlat Publishing, LLC and Affiliates, All Rights Reserved.